<html><body>
<p><b><u>Allergies</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Results</u></b></p>
<p>No Results</p>
<br/>
<p><b><u>Reason For Referral</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>REASON FOR VISIT</u></b></p>
<p>Lab review</p>
<br/>
<p><b><u>Medications</u></b></p>
<p>Medication</p>
<p>SIG (Take, Route, Frequency, Duration)</p>
<p>Notes</p>
<p>Start Date</p>
<p>End Date</p>
<p>Status</p>
<p>Olmesartan Medoxomil-HCTZ 40-12.5 MG</p>
<p>1 tablet Orally Once a day; Duration: 30 days</p>
<p>Active</p>
<br/>
<p><b><u>Immunizations</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Social History</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Problems</u></b></p>
<p>Problem Type</p>
<p>SNOMED Code</p>
<p>ICD Code</p>
<p>Onset Dates</p>
<p>Problem Status</p>
<p>W/U Status</p>
<p>Risk</p>
<p>Notes</p>
<p>Problem</p>
<p>Vitamin D deficiency (34713006)</p>
<p>Vitamin D deficiency, unspecified (E55.9)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Disorder of lipoprotein AND/OR lipid metabolism (48286001)</p>
<p>Other lipoprotein metabolism disorders (E78.89)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Hyperlipidemia (55822004)</p>
<p>Hyperlipidemia, unspecified (E78.5)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Essential hypertension (59621000)</p>
<p>Hypertension, unspecified type (I10)</p>
<p>Active</p>
<p>confirmed</p>
<p>Problem</p>
<p>Skin sensation disturbance (80910005)</p>
<p>Tingling of both feet (R20.2)</p>
<p>Active</p>
<p>confirmed</p>
<br/>
<p><b><u>Vital Signs</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Procedures</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Encounters</u></b></p>
<p>Encounter</p>
<p>Location</p>
<p>Date</p>
<p>Provider</p>
<p>Diagnosis</p>
<p>Epic Heart And Vascular Care</p>
<p>4 HDSN VLY PROF PLZ STE B NEWBURGH, NY 12550-3157</p>
<p>07/19/2025</p>
<p>Shellene Napier-Martin</p>
<p>Annual physical exam Z00.00 ; Person consulting for explanation of examination or test findings Z71.2 ; Hypertension, unspecified type I10 ; Hyperlipidemia, unspecified E78.5 ; SVT (supraventricular tachycardia) I47.10 ; Shortness of breath on exertion R06.02 ; Dizziness R42 ; Lightheadedness R42 ; Leg numbness R20.0 ; Tingling of both feet R20.2 and Abnormal ankle brachial index (ABI) R68.89</p>
<br/>
<p><b><u>Medical Equipment</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Assessments</u></b></p>
<p>Encounter Date</p>
<p>Diagnosis (ICD Code)</p>
<p>Treatment Notes</p>
<p>Section Notes</p>
<p>encounter date : 07/19/2025</p>
<p>Annual physical exam (ICD-10 - Z00.00)</p>
<p>encounter date : 07/19/2025</p>
<p>Person consulting for explanation of examination or test findings (ICD-10 - Z71.2)</p>
<p>encounter date : 07/19/2025</p>
<p>Hypertension, unspecified type (ICD-10 - I10)</p>
<p>encounter date : 07/19/2025</p>
<p>Hyperlipidemia, unspecified (ICD-10 - E78.5)</p>
<p>encounter date : 07/19/2025</p>
<p>SVT (supraventricular tachycardia) (ICD-10 - I47.10)</p>
<p>encounter date : 07/19/2025</p>
<p>Shortness of breath on exertion (ICD-10 - R06.02)</p>
<p>encounter date : 07/19/2025</p>
<p>Dizziness (ICD-10 - R42)</p>
<p>encounter date : 07/19/2025</p>
<p>Lightheadedness (ICD-10 - R42)</p>
<p>encounter date : 07/19/2025</p>
<p>Leg numbness (ICD-10 - R20.0)</p>
<p>encounter date : 07/19/2025</p>
<p>Tingling of both feet (ICD-10 - R20.2)</p>
<p>encounter date : 07/19/2025</p>
<p>Abnormal ankle brachial index (ABI) (ICD-10 - R68.89)</p>
<p>encounter date : 07/19/2025</p>
<p>Other</p>
<p>Labs</p>
<p>were reviewed and discussed today that showed</p>
<p>an LDL of 129 and an A1C of 5.0. Thyroid function, CMP, hepatic</p>
<p>panel, lipoprotein a, CBC, vitamin D, and apolipoprotein B were</p>
<p>reviewed and found to be within normal limits. Lyme panel was</p>
<p>negative. Due to the mild elevation in LDL, she was advised to adopt</p>
<p>a diet low in saturated fats and high in fiber, as well as to</p>
<p>increase aerobic exercise. A repeat lipid panel is recommended in 3-6</p>
<p>months to assess response to lifestyle modifications. Follow-up is</p>
<p>scheduled for 07/21. She is in agreement with the plan of care.</p>
<p>Patient was informed of the telemedicine visit by our office staff. Telemedicine was described in detail to the patient as the use of synchronous video and audio communication to provide clinical care from a distance. A telemedicine visit can provide the same medical standard of care for specific conditions. The patient was informed that the practice staff located at the provider's office would assist in carrying out any recommendations and clinical care.</p>
<p>Patient Location: Home</p>
<p>Lack of strict HIPPA Rules. Patient expressed verbal interest in the telemedicine visit and granted consent to proceed.</p>
<br/>
<p><b><u>Plan Of Treatment</u></b></p>
<p>Treatment Notes</p>
<p>Assessment</p>
<p>Notes</p>
<p>Other</p>
<p>Labs</p>
<p>were reviewed and discussed today that showed</p>
<p>an LDL of 129 and an A1C of 5.0. Thyroid function, CMP, hepatic</p>
<p>panel, lipoprotein a, CBC, vitamin D, and apolipoprotein B were</p>
<p>reviewed and found to be within normal limits. Lyme panel was</p>
<p>negative. Due to the mild elevation in LDL, she was advised to adopt</p>
<p>a diet low in saturated fats and high in fiber, as well as to</p>
<p>increase aerobic exercise. A repeat lipid panel is recommended in 3-6</p>
<p>months to assess response to lifestyle modifications. Follow-up is</p>
<p>scheduled for 07/21. She is in agreement with the plan of care.</p>
<p>Patient was informed of the telemedicine visit by our office staff. Telemedicine was described in detail to the patient as the use of synchronous video and audio communication to provide clinical care from a distance. A telemedicine visit can provide the same medical standard of care for specific conditions. The patient was informed that the practice staff located at the provider's office would assist in carrying out any recommendations and clinical care.</p>
<p>Patient Location: Home</p>
<p>Lack of strict HIPPA Rules. Patient expressed verbal interest in the telemedicine visit and granted consent to proceed.</p>
<p>Next Appt</p>
<p>Details</p>
<p>Follow Up: 07/21, Reason:</p>
<p>Provider Name:RISHI BAJAJ, 09/15/2025 10:00:00 AM, 4 HDSN VLY PROF PLZ, Suite B, NEWBURGH, NY, 12550-3157, 781-530-0070</p>
<br/>
<p><b><u>Goals Section</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Health Concerns</u></b></p>
<p>No Information</p>
<br/>
<p><b><u>Insurance Providers</u></b></p>
<p>Payer Name</p>
<p>Payer Address</p>
<p>Payer Phone</p>
<p>Subscriber Number</p>
<p>Group Number</p>
<p>Insured Name</p>
<p>Patient Relationship to Insured</p>
<p>Coverage Start Date</p>
<p>Coverage End Date</p>
<p>MVP Health Plan of NY</p>
<p>PO BOX 2207 SCHENECTADY, NY 123012207</p>
<p>800-684-9286</p>
<p>82126914200</p>
<p>Amanna, Courtney</p>
<p>Self - patient is the insured</p>
<p>Medicaid of New York</p>
<p>PO BOX 4601 RENSSELAER, NY 121444602</p>
<p>DG94536D</p>
<p>Amanna, Courtney</p>
<p>Self - patient is the insured</p>
<br/>
</body></html>
